Thinking and memory tests for brain lymphoma or low-grade glioma
Part of Brain & nervous system, Cancer, Mental health clinical trials.
This study uses neurocognitive tests to check thinking and memory skills in people newly diagnosed with certain brain tumors. It aims to understand how these tumors affect the brain before treatment begins.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a newly diagnosed brain lymphoma (DLBCL) or a low-grade glioma with an IDH mutation.
- You were diagnosed with low-grade glioma within the last year and haven't started tumor treatment yet.
- You are 18 years old or older.
- You can read regular sized print with glasses if needed.
- You do not have severe psychiatric or substance abuse issues that would interfere with the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies how radiotherapy affects memory and thinking in adults with certain brain or skull-base tumors. It may help doctors understand who is most likely to have thinking changes and how to monitor or support patients.
This study looks at how cancer and its treatment affect thinking and memory. It may help find ways to protect brain function during radiotherapy.
This study offers cognitive rehabilitation and long-term monitoring for adults with lower grade gliomas. It aims to help improve thinking and memory problems you may be experiencing.
This study looks at how thinking and memory may be affected in people newly diagnosed with a type of lymphoma called diffuse large B-cell lymphoma (DLBCL) who are about to start a common chemotherapy regimen known as R-CHOP. It also includes a comparison group of healthy relatives. The goal is to understand how treatment may affect cognitive function over time.
This trial studies how radiation therapy affects thinking and memory in adults with certain brain tumors. It may help doctors understand which patients are more likely to have cognitive side effects and how to measure them over time.
This study looks at how primary central nervous system (CNS) lymphoma can be identified and tracked using scans and molecular (tissue/biomarker) tests. It may help doctors better understand your disease and choose the best next steps.
Hear when a new Brain Tumor trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.